Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2000106	注射用重组人血小板生成素拟肽-Fc融合蛋白		Biological Products(1)	New Drug Application	2020-05-20	齐鲁制药有限公司	QILU Pharmaceutical Co Ltd	In Review	2020-05-19	view
CXSL2000107	注射用重组人血小板生成素拟肽-Fc融合蛋白		Biological Products(1)	New Drug Application	2020-05-20	齐鲁制药有限公司	QILU Pharmaceutical Co Ltd	In Review	2020-05-19	view
CXSL1700008	注射用重组人血小板生成素拟肽-Fc融合蛋白		Biological Products(7)	New Drug Application	2017-03-30	四川科伦博泰生物医药股份有限公司	Sichuan Kelun-Biotech Biopharmaceutical Co Ltd	Certificate Issued	2018-07-27	view
CXSL1300075	注射用重组人血小板生成素拟肽-Fc融合蛋白		Biological Products(7)	New Drug Application	2013-11-01	齐鲁制药有限公司	QILU Pharmaceutical Co Ltd	Certificate Issued	2016-03-25	view
CXSL1300074	注射用重组人血小板生成素拟肽-Fc融合蛋白		Biological Products(7)	New Drug Application	2013-11-01	齐鲁制药有限公司	QILU Pharmaceutical Co Ltd	Certificate Issued	2016-03-25	view
CXSL2500005	注射用重组人血小板生成素	recombinant human thrombopoietin	Biological Products(2.1)	New Drug Application	2025-01-03		Shenyang Sunshine Pharmaceutical Co Ltd			view